Viewing nowLipinon 40 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 41.44mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

MFDS item code 200706542 · Notified 2007.06.07 · Insurance code 642500650
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It is particularly effective in lowering the risk of myocardial infarction, stroke, complications after vascular surgeries, and hospitalizations due to angina and congestive heart failure. It also reduces the risk of cardiovascular complications in patients with Type 2 diabetes or those with multiple risk factors. Additionally, it is used in the treatment of hyperlipidemia, reducing LDL cholesterol and total cholesterol levels while increasing HDL cholesterol, thereby improving blood lipid status. Due to these actions, it plays a vital role in the prevention and treatment of cardiovascular diseases. In summary, this medicine is used for improving cardiovascular diseases and hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be started with 20 mg or 40 mg once daily (only when an LDL cholesterol reduction of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, measuring LDL cholesterol is recommended when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
This medication may cause muscle-related symptoms; therefore, it is essential to discontinue use and consult a doctor immediately if severe muscle pain or weakness occurs. This drug may impact liver function, so it should not be used in patients with liver disease or elevated liver function test values. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication. It should not be administered to children under 10 or patients with specific genetic lactose intolerance. Patients who are alcoholic or have a history of liver disease, those with impaired kidney function, and the elderly should use this drug with caution and may require regular monitoring. This medication can interact with various other drugs, so it is crucial to inform your doctor or pharmacist of any other medications you are taking. Be particularly cautious when taken with specific antibiotics, antifungals, antivirals, and immunosuppressants. During the intake of this medicine, liver function and muscle condition should be monitored regularly, and treatment should be discontinued immediately if abnormalities are found. Moreover, it should be avoided to consume grapefruit juice simultaneously, as it may increase blood concentration and the risk of side effects. In case of overdose, there is no specific antidote, so you should seek medical attention immediately for symptomatic treatment. This medication should be stored out of reach of children, and kept in its original container to prevent misuse or deterioration.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the medicine.
This medicine is a white, oval film-coated tablet.
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 41.44mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.